Global Bio-pharma Market 2016 Industry Overview, Outlook, Structure and Forecast to 2021

Global Bio-pharma Market 2016, presents a professional and in-depth study on the current state of the Bio-pharma Market globally, providing basic overview of Bio-pharma Market including definitions, classifications, applications and industry chain structure, Bio-pharma Market report provides development policies and plans are discussed as well as manufacturing processes and cost structure. Bio-pharma Market size, share and end users are analyzed as well as segment markets by types, applications and companies.

The Current global Bio-pharma Market Analysis and opportunities are also taken into consideration in Bio-pharma Market industry study. Bio-pharma Market report provides the feasibility of new investment projects is assessed, and overall research conclusions are offered.

This report studies Bio-pharma in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer

Download for Sample Report @

Covering Manufacturers
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Bio-pharma in these regions, from 2011 to 2021

Access Full Report With TOC @

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Recombinant Human Insulin
Growth Hormones
Purified Proteins

Split by application, this report focuses on consumption, market share and growth rate of Bio-pharma in each application, can be divided into
Metabolic Disorders
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases

Table of Contents

Global Bio-pharma Market Research Report 2016
1 Bio-pharma Market Overview
1.1 Product Overview and Scope of Bio-pharma
1.2 Bio-pharma Segment by Type
1.2.1 Global Production Market Share of Bio-pharma by Type in 2015
1.2.2 Monoclonal Antibodies
1.2.3 Recombinant Proteins
1.2.4 Granulocyte-Colony Stimulating Factor (G-CSF)
1.2.5 Interferons
1.2.6 Recombinant Human Insulin
1.2.7 Erythropoietin
1.2.8 Vaccines
1.2.9 Growth Hormones
1.2.10 Purified Proteins
1.2.11 Others
1.3 Bio-pharma Segment by Application
1.3.1 Bio-pharma Consumption Market Share by Application in 2015
1.3.2 Metabolic Disorders
1.3.3 Oncology
1.3.4 Neurological Disorders
1.3.5 Cardiovascular Diseases
1.3.6 Inflammatory and Infectious Diseases
1.3.7 Others
1.4 Bio-pharma Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Bio-pharma (2011-2021)

Contact Us

Mark Stone
Sales Manager
Phone: (201) 465-4211

Designed by
Powered by
%d bloggers like this: